Screener
Trevi Therapeutics, Inc. TRVI Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Trevi Therapeutics, Inc.’s reported figures.
The source filing: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206390
FAQ
- What is Trevi Therapeutics, Inc.'s invested capital?
- Trevi Therapeutics, Inc. (TRVI) reported invested capital of $153.4M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s invested capital changed year-over-year?
- Trevi Therapeutics, Inc.'s invested capital increased by 89.3% year-over-year, from $81.04M to $153.4M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s invested capital has grown at a 56.7% compound annual growth rate (CAGR), from -$17.46M to $165.08M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Trevi Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude